US Stock MarketDetailed Quotes

RDY Dr Reddy's Laboratories Ltd

Watchlist
  • 69.650
  • -0.020-0.03%
Close May 15 16:00 ET
  • 69.650
  • 0.0000.00%
Post 17:30 ET
11.60BMarket Cap17.36P/E (TTM)

Dr Reddy's Laboratories Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
(Q4)Mar 31, 2023
(Q3)Dec 31, 2022
(Q2)Sep 30, 2022
(Q1)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-22.83%45.43B
-41.46%11.52B
-79.63%4.74B
93.15%17.93B
69.05%11.25B
109.46%58.88B
3,218.55%19.68B
-10.04%23.26B
81.77%9.28B
293.01%6.66B
Net income from continuing operations
59.78%72.01B
206.46%29.4B
10.57%13.79B
33.00%14.8B
18.10%14.03B
91.22%45.07B
996.23%9.59B
76.52%12.47B
12.18%11.13B
108.06%11.88B
Operating gains losses
-43.51%-1.58B
60.75%-157M
250.53%286M
-135.23%-1.1B
83.40%-605M
57.46%-1.1B
14.89%-400M
-30.14%-190M
330.27%3.13B
-496.56%-3.65B
Depreciation and amortization
16.33%14.7B
12.01%3.57B
15.26%3.77B
21.21%3.79B
17.02%3.57B
6.87%12.64B
7.81%3.19B
9.91%3.27B
4.72%3.13B
4.99%3.05B
Deferred tax
----
----
15.30%4.47B
-13.02%4.33B
59.70%4.44B
75.26%15.3B
127.80%3.66B
46.56%3.88B
80.48%4.98B
61.85%2.78B
Other non cash items
-328.63%-567M
55.00%-54M
-230.34%-189M
-493.55%-366M
-67.69%42M
3,642.86%248M
-101.40%-120M
101.69%145M
3,200.00%93M
912.50%130M
Change In working capital
-156.93%-20.18B
-142.05%-2.76B
-354.13%-11.86B
123.12%2.61B
-4.77%-8.17B
57.54%-7.86B
144.81%6.57B
-69.27%4.67B
-62.50%-11.29B
35.38%-7.8B
-Change in receivables
-40.02%-8.05B
-177.11%-1.92B
-561.61%-8.83B
297.68%7.34B
27.83%-4.65B
66.19%-5.75B
159.98%2.49B
-68.98%1.91B
50.86%-3.71B
43.91%-6.44B
-Change in inventory
-594.99%-18.45B
-3,124.79%-3.9B
-216.68%-5.2B
-471.70%-4.7B
-115.22%-4.64B
73.22%-2.65B
99.15%-121M
-119.21%-1.64B
18.11%1.27B
59.79%-2.16B
-Change in payables and accrued expense
14,943.48%3.46B
-290.10%-1.5B
-85.88%390M
228.65%2.34B
516.48%2.22B
-99.48%23M
-138.59%-384M
282.14%2.76B
-1,339.46%-1.82B
-111.16%-534M
-Change in other working capital
441.10%2.86B
-0.72%4.56B
9.25%1.78B
66.25%-2.37B
-183.94%-1.11B
-86.85%528M
72.16%4.59B
-17.65%1.63B
-1,046.90%-7.02B
6,127.27%1.33B
Cash from discontinued investing activities
Operating cash flow
-22.83%45.43B
-41.46%11.52B
-79.63%4.74B
93.15%17.93B
69.05%11.25B
109.46%58.88B
115.80%19.68B
34.21%23.26B
81.77%9.28B
293.01%6.66B
Investing cash flow
Cash flow from continuing investing activities
2.63%-40.28B
28.04%-11.35B
38.74%-16.18B
-178.79%-4.52B
-67.30%-8.24B
-56.79%-41.37B
28.27%-15.77B
-856.54%-26.41B
44.44%5.73B
12.20%-4.92B
Capital expenditure reported
----
----
-62.70%-5.04B
-18.32%-3.94B
-40.06%-12.17B
0.96%-18.87B
6.93%-3.75B
30.73%-3.1B
53.83%-3.33B
-160.41%-8.69B
Net PPE purchase and sale
-18,806.10%-15.34B
-62,984.62%-16.35B
6,450.00%524M
457.25%468M
-89.39%19M
-77.84%82M
-85.47%26M
-78.38%8M
-222.43%-131M
280.85%179M
Net intangibles purchase and sale
---11.01B
---11.03B
--0
----
----
--0
--0
--0
----
----
Net business purchase and sale
---12M
--0
----
----
----
--0
--0
----
----
----
Net investment purchase and sale
32.79%-15.7B
54.80%-5.55B
49.05%-11.96B
-119.68%-1.75B
1.43%3.56B
-108.61%-23.37B
31.87%-12.27B
-1,759.36%-23.48B
11.50%8.88B
236.54%3.51B
Cash from discontinued investing activities
Investing cash flow
2.63%-40.28B
28.04%-11.35B
38.74%-16.18B
-178.79%-4.52B
-67.30%-8.24B
-56.79%-41.37B
28.27%-15.77B
-856.54%-26.41B
44.44%5.73B
12.20%-4.92B
Financing cash flow
Cash flow from continuing financing activities
85.99%-3.76B
87.60%-533M
806.00%5.28B
43.01%-7.04B
86.33%-1.48B
-1,009.04%-26.86B
-184.32%-4.3B
122.70%583M
-71.19%-12.35B
-577.66%-10.8B
Net issuance payments of debt
121.31%4.35B
102.64%109M
431.54%5.82B
91.70%-587M
90.37%-991M
-845.78%-20.4B
-176.45%-4.13B
149.80%1.09B
-141.66%-7.07B
-518.97%-10.29B
Net common stock issuance
118.75%805M
-85.97%31M
-88.89%9M
1,860.00%686M
154.84%79M
10.18%368M
2,662.50%221M
80.00%81M
-73.88%35M
-78.91%31M
Cash dividends paid
-33.52%-6.65B
--0
--0
-33.52%-6.65B
--0
-20.09%-4.98B
--0
--0
-20.09%-4.98B
--0
Cash from discontinued financing activities
Financing cash flow
85.99%-3.76B
87.60%-533M
806.00%5.28B
43.01%-7.04B
86.33%-1.48B
-1,009.04%-26.86B
-184.32%-4.3B
122.70%583M
-71.19%-12.35B
-577.66%-10.8B
Net cash flow
Beginning cash position
-61.09%5.78B
20.39%7.54B
48.85%13.54B
14.78%7.23B
-61.09%5.78B
0.22%14.85B
-71.52%6.26B
-8.89%9.09B
-22.91%6.3B
0.22%14.85B
Current changes in cash
114.82%1.39B
7.40%-363M
-140.01%-6.16B
138.87%6.37B
116.96%1.54B
-1,235.09%-9.36B
94.96%-392M
-121.39%-2.57B
43.21%2.67B
-33.47%-9.07B
Effect of exchange rate changes
-120.63%-59M
26.14%-65M
160.30%161M
-151.56%-66M
-117.35%-89M
-60.98%286M
-113.58%-88M
-4,350.00%-267M
350.98%128M
261.27%513M
End cash Position
22.98%7.11B
22.98%7.11B
20.39%7.54B
48.85%13.54B
14.78%7.23B
-61.09%5.78B
-61.09%5.78B
-71.52%6.26B
-8.89%9.09B
-22.91%6.3B
Free cash flow
-55.02%18B
-67.13%5.24B
-101.51%-305M
135.00%13.99B
54.74%-921M
341.65%40.01B
212.86%15.93B
56.81%20.16B
382.76%5.95B
70.01%-2.04B
Currency Unit
INR
INR
INR
INR
INR
INR
INR
INR
INR
INR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023(Q4)Mar 31, 2023(Q3)Dec 31, 2022(Q2)Sep 30, 2022(Q1)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -22.83%45.43B-41.46%11.52B-79.63%4.74B93.15%17.93B69.05%11.25B109.46%58.88B3,218.55%19.68B-10.04%23.26B81.77%9.28B293.01%6.66B
Net income from continuing operations 59.78%72.01B206.46%29.4B10.57%13.79B33.00%14.8B18.10%14.03B91.22%45.07B996.23%9.59B76.52%12.47B12.18%11.13B108.06%11.88B
Operating gains losses -43.51%-1.58B60.75%-157M250.53%286M-135.23%-1.1B83.40%-605M57.46%-1.1B14.89%-400M-30.14%-190M330.27%3.13B-496.56%-3.65B
Depreciation and amortization 16.33%14.7B12.01%3.57B15.26%3.77B21.21%3.79B17.02%3.57B6.87%12.64B7.81%3.19B9.91%3.27B4.72%3.13B4.99%3.05B
Deferred tax --------15.30%4.47B-13.02%4.33B59.70%4.44B75.26%15.3B127.80%3.66B46.56%3.88B80.48%4.98B61.85%2.78B
Other non cash items -328.63%-567M55.00%-54M-230.34%-189M-493.55%-366M-67.69%42M3,642.86%248M-101.40%-120M101.69%145M3,200.00%93M912.50%130M
Change In working capital -156.93%-20.18B-142.05%-2.76B-354.13%-11.86B123.12%2.61B-4.77%-8.17B57.54%-7.86B144.81%6.57B-69.27%4.67B-62.50%-11.29B35.38%-7.8B
-Change in receivables -40.02%-8.05B-177.11%-1.92B-561.61%-8.83B297.68%7.34B27.83%-4.65B66.19%-5.75B159.98%2.49B-68.98%1.91B50.86%-3.71B43.91%-6.44B
-Change in inventory -594.99%-18.45B-3,124.79%-3.9B-216.68%-5.2B-471.70%-4.7B-115.22%-4.64B73.22%-2.65B99.15%-121M-119.21%-1.64B18.11%1.27B59.79%-2.16B
-Change in payables and accrued expense 14,943.48%3.46B-290.10%-1.5B-85.88%390M228.65%2.34B516.48%2.22B-99.48%23M-138.59%-384M282.14%2.76B-1,339.46%-1.82B-111.16%-534M
-Change in other working capital 441.10%2.86B-0.72%4.56B9.25%1.78B66.25%-2.37B-183.94%-1.11B-86.85%528M72.16%4.59B-17.65%1.63B-1,046.90%-7.02B6,127.27%1.33B
Cash from discontinued investing activities
Operating cash flow -22.83%45.43B-41.46%11.52B-79.63%4.74B93.15%17.93B69.05%11.25B109.46%58.88B115.80%19.68B34.21%23.26B81.77%9.28B293.01%6.66B
Investing cash flow
Cash flow from continuing investing activities 2.63%-40.28B28.04%-11.35B38.74%-16.18B-178.79%-4.52B-67.30%-8.24B-56.79%-41.37B28.27%-15.77B-856.54%-26.41B44.44%5.73B12.20%-4.92B
Capital expenditure reported ---------62.70%-5.04B-18.32%-3.94B-40.06%-12.17B0.96%-18.87B6.93%-3.75B30.73%-3.1B53.83%-3.33B-160.41%-8.69B
Net PPE purchase and sale -18,806.10%-15.34B-62,984.62%-16.35B6,450.00%524M457.25%468M-89.39%19M-77.84%82M-85.47%26M-78.38%8M-222.43%-131M280.85%179M
Net intangibles purchase and sale ---11.01B---11.03B--0----------0--0--0--------
Net business purchase and sale ---12M--0--------------0--0------------
Net investment purchase and sale 32.79%-15.7B54.80%-5.55B49.05%-11.96B-119.68%-1.75B1.43%3.56B-108.61%-23.37B31.87%-12.27B-1,759.36%-23.48B11.50%8.88B236.54%3.51B
Cash from discontinued investing activities
Investing cash flow 2.63%-40.28B28.04%-11.35B38.74%-16.18B-178.79%-4.52B-67.30%-8.24B-56.79%-41.37B28.27%-15.77B-856.54%-26.41B44.44%5.73B12.20%-4.92B
Financing cash flow
Cash flow from continuing financing activities 85.99%-3.76B87.60%-533M806.00%5.28B43.01%-7.04B86.33%-1.48B-1,009.04%-26.86B-184.32%-4.3B122.70%583M-71.19%-12.35B-577.66%-10.8B
Net issuance payments of debt 121.31%4.35B102.64%109M431.54%5.82B91.70%-587M90.37%-991M-845.78%-20.4B-176.45%-4.13B149.80%1.09B-141.66%-7.07B-518.97%-10.29B
Net common stock issuance 118.75%805M-85.97%31M-88.89%9M1,860.00%686M154.84%79M10.18%368M2,662.50%221M80.00%81M-73.88%35M-78.91%31M
Cash dividends paid -33.52%-6.65B--0--0-33.52%-6.65B--0-20.09%-4.98B--0--0-20.09%-4.98B--0
Cash from discontinued financing activities
Financing cash flow 85.99%-3.76B87.60%-533M806.00%5.28B43.01%-7.04B86.33%-1.48B-1,009.04%-26.86B-184.32%-4.3B122.70%583M-71.19%-12.35B-577.66%-10.8B
Net cash flow
Beginning cash position -61.09%5.78B20.39%7.54B48.85%13.54B14.78%7.23B-61.09%5.78B0.22%14.85B-71.52%6.26B-8.89%9.09B-22.91%6.3B0.22%14.85B
Current changes in cash 114.82%1.39B7.40%-363M-140.01%-6.16B138.87%6.37B116.96%1.54B-1,235.09%-9.36B94.96%-392M-121.39%-2.57B43.21%2.67B-33.47%-9.07B
Effect of exchange rate changes -120.63%-59M26.14%-65M160.30%161M-151.56%-66M-117.35%-89M-60.98%286M-113.58%-88M-4,350.00%-267M350.98%128M261.27%513M
End cash Position 22.98%7.11B22.98%7.11B20.39%7.54B48.85%13.54B14.78%7.23B-61.09%5.78B-61.09%5.78B-71.52%6.26B-8.89%9.09B-22.91%6.3B
Free cash flow -55.02%18B-67.13%5.24B-101.51%-305M135.00%13.99B54.74%-921M341.65%40.01B212.86%15.93B56.81%20.16B382.76%5.95B70.01%-2.04B
Currency Unit INRINRINRINRINRINRINRINRINRINR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg